Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-20

Clinical Trial Update: Rosuvastatin Calcium Bioequivalence Study - Fast [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of rosuvastatin calcium completed for hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypercholesterolaemia | Phase 1 | Status: COMPLETED